Risk of suicide among users of calcium channel blockers: population based, nested case-control study.
Gasse
C
C
Boston Collaborative Drug Surveillance Program, Boston University School of Medicine, Lexington, MA 02421, USA. cgasse@bu.edu
Derby
L E
LE
Vasilakis
C
C
Jick
H
H
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D015992:Body Mass Index; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D016022:Case-Control Studies; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D016015:Logistic Models; D001523:Mental Disorders / Q000150:complications; D018570:Risk Assessment; D013405:Suicide
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D004232:Diuretics